Nufox

Clinical Trials Overview

1 trials found
About Nufox

Nufox is not currently approved or widely used in the treatment of colorectal cancer. Its clinical efficacy and safety profile have yet to be established through clinical trials specific to colorectal cancer patients.

Category Other Medications
Mechanism Nufox is an investigational drug and its mechanism of action has not been fully elucidated or approved by the FDA for use in colorectal cancer.
1
Total Trials
0
Recruiting
0
Active
1
Completed
111
Total Enrollment
3
Countries
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
NCT03428958 Phase 1 Completed 111 patients
Start: Oct 2018
End: Mar 2024
INTERVENTIONAL
Medications: Bevacizumab Leucovorin NUC-3373 Nufiri Nufox
This is a three-part study of NUC-3373 administered by intravenous (IV) infusion across two administration schedules, either as monotherapy or as part of various combinations with agents commonly used to treat CRC (leucovorin, oxaliplatin, irinotecan...
United States, France, United Kingdom
View Details ClinicalTrials.gov Am I eligible?
Back to Drug Glossary View All Trials